CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 258 filers reported holding CRISPR THERAPEUTICS AG in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,074 | -19.1% | 266 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $14,933 | -31.4% | 266 | -44.7% | 0.00% | -33.3% |
| Q1 2023 | $21,756 | +108680.0% | 481 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $20 | -100.0% | 481 | -97.4% | 0.00% | -98.4% |
| Q3 2022 | $1,188,000 | +56.3% | 18,182 | +45.3% | 0.19% | +54.5% |
| Q2 2022 | $760,000 | -60.7% | 12,514 | -59.4% | 0.12% | -49.0% |
| Q1 2022 | $1,934,000 | -22.3% | 30,811 | -6.1% | 0.24% | -15.4% |
| Q4 2021 | $2,488,000 | -34.6% | 32,828 | -3.4% | 0.28% | -39.0% |
| Q3 2021 | $3,803,000 | -30.6% | 33,974 | +0.4% | 0.47% | -26.7% |
| Q2 2021 | $5,478,000 | +26.5% | 33,836 | -4.8% | 0.64% | +20.6% |
| Q1 2021 | $4,331,000 | +23.4% | 35,540 | -15.3% | 0.53% | +5.2% |
| Q3 2020 | $3,510,000 | +13.7% | 41,966 | -0.1% | 0.50% | -0.8% |
| Q2 2020 | $3,088,000 | +41.7% | 42,026 | -18.2% | 0.51% | +14.7% |
| Q1 2020 | $2,179,000 | -57.1% | 51,371 | -38.4% | 0.44% | -29.4% |
| Q4 2019 | $5,082,000 | +57.3% | 83,448 | +5.9% | 0.62% | +34.1% |
| Q3 2019 | $3,231,000 | -19.9% | 78,819 | -7.9% | 0.47% | -15.7% |
| Q2 2019 | $4,032,000 | +67.6% | 85,599 | +109.1% | 0.55% | +83.7% |
| Q2 2018 | $2,406,000 | +141.6% | 40,939 | +87.9% | 0.30% | +129.8% |
| Q1 2018 | $996,000 | -16.9% | 21,790 | -57.3% | 0.13% | -17.1% |
| Q4 2017 | $1,199,000 | – | 51,080 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |